HMGB1 and heart failure: In vivo, using a murine model of heart failure, intramyocardial HMGB1 injection attenuated LV remodeling most likely through the inhibition of TGF β/Smad signaling pathway known to play an important role in the pathogenesis of cardiac remodeling and fibrosis [124].